Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Neurology|August 21, 2023
Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson DiseaseSiegfried Karl Wagner, David Romero-Bascones, Mario Cortina-Borja, et al.Lancet (London, England)|June 29, 2020
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trialRaj R Makkar, Wen Cheng, Ron Waksman, et al.The Journal of Thoracic and Cardiovascular Surgery|August 26, 2014
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgeryMichael J Reardon, David H Adams, Joseph S Coselli, et al.The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.Journal of the American College of Cardiology|February 1, 2023
Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral RegurgitationJörg Hausleiter, D Scott Lim, Linda D Gillam, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.Pageof 10